ZIPPIN BIO CORPORATION

Biotech · Private

ZippinCarriers, ultrasmall nanoparticles that deliver oligonucleotides and other molecules across the blood-brain barrier to the central nervous system

Grants
$485K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel carriers for enhanced oligonucleotide permeability through the blood-brain barrier$485,442
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2586Bit Discovery, Inc.—$760K
2587AAKHA BIOLOGICS INC.—$750K
2588ENDURE BIOTHERAPEUTICS, INC.——
2589ZIPPIN BIO CORPORATION——
2590SIRPANT IMMUNOTHERAPEUTICS INC——
2591SACYL PHARMACEUTICALS, INC.——
2592HELICAL BIOSCIENCES LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.